{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:15:01Z","timestamp":1779282901079,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bulcan.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:14:48Z","timestamp":1778188488000},"page":"S24-S30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques chez des personnes vivant avec le VIH (SFGM-TC)"],"prefix":"10.1016","volume":"113","author":[{"given":"Anne-Claire","family":"Mamez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Berceanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imane","family":"Merhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-2937","authenticated-orcid":false,"given":"Patrice","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11S","key":"10.1016\/j.bulcan.2026.03.003_bib0005","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"Ateliers d\u2019harmonisation des pratiques de la SFGM-TC [Harmomization of clinical practices among the SFGM-TC]","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"issue":"18","key":"10.1016\/j.bulcan.2026.03.003_bib0010","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2017-04-551606","article-title":"How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation","volume":"130","author":"Alvarnas","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bulcan.2026.03.003_bib0015","first-page":"1195","article-title":"Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma","volume":"18","author":"Gabarre","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.bulcan.2026.03.003_bib0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM198309153091114","article-title":"Bone-marrow transplantation in AIDS","volume":"309","author":"Hassett","year":"1983","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bulcan.2026.03.003_bib0025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7326\/0003-4819-111-12-973","article-title":"Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma","volume":"111","author":"Holland","year":"1989","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.bulcan.2026.03.003_bib0030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5\u00a0Delta32\/Delta32\u00a0stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.bulcan.2026.03.003_bib0035","doi-asserted-by":"crossref","first-page":"e13095","DOI":"10.1111\/ctr.13095","article-title":"The effect of CCR5\u039432 on the risk of grade 3-4 acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"31","author":"Niu","year":"2017","journal-title":"Clin Transplant"},{"issue":"25","key":"10.1016\/j.bulcan.2026.03.003_bib0040","first-page":"2438","article-title":"More on shift of HIV tropism in stem-cell transplantation with CCR5\u00a0delta32\/delta32\u00a0mutation","volume":"371","author":"Verheyen","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bulcan.2026.03.003_bib0045","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2352-3018(20)30069-2","article-title":"Evidence for HIV-1\u00a0cure after CCR5\u039432\/\u039432\u00a0allogeneic haemopoietic stem-cell transplantation 30\u00a0months post-analytical treatment interruption: a case report","volume":"7","author":"Gupta","year":"2020","journal-title":"Lancet HIV"},{"issue":"6","key":"10.1016\/j.bulcan.2026.03.003_bib0050","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S2352-3018(15)00083-1","article-title":"CCR5 \u039432\u00a0homozygous cord blood allogeneic transplantation in a patient with HIV: a case report","volume":"2","author":"Duarte","year":"2015","journal-title":"Lancet HIV"},{"issue":"6","key":"10.1016\/j.bulcan.2026.03.003_bib0055","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2023.02.030","article-title":"HIV-1\u00a0remission and possible cure in a woman after haplo-cord blood transplant","volume":"186","author":"Hsu","year":"2023","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bulcan.2026.03.003_bib0060","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1038\/s41591-024-03277-z","article-title":"Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5\u00a0donor cells","volume":"30","author":"Saez-Cirion","year":"2024","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.bulcan.2026.03.003_bib0065","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/s41409-019-0480-x","article-title":"Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party","volume":"54","author":"H\u00fcbel","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"10.1016\/j.bulcan.2026.03.003_bib0070","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1182\/blood-2008-12-195388","article-title":"Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation","volume":"113","author":"Diez-Martin","year":"2009","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bulcan.2026.03.003_bib0075","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2008.18.2683","article-title":"Autologous stem-cell transplantation in patients with HIV-related lymphoma","volume":"27","author":"Balsalobre","year":"2009","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.003_bib0080","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbmt.2010.03.019","article-title":"HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)","volume":"16","author":"Krishnan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.bulcan.2026.03.003_bib0085","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood-2015-08-664706","article-title":"Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803\/AMC 071\u00a0trial","volume":"128","author":"Alvarnas","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bulcan.2026.03.003_bib0090","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.2010.04312.x","article-title":"Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25\u00a0years","volume":"163","author":"H\u00fctter","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.bulcan.2026.03.003_bib0095","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.bbmt.2019.06.033","article-title":"Allogeneic hematopoietic cell transplant for hiv patients with hematologic malignancies: the BMT CTN-0903\/AMC-080\u00a0trial","volume":"25","author":"Ambinder","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2026.03.003_bib0100","unstructured":"EBMT Handbook 2024, chapitre 88. https:\/\/www.ebmt.org\/sites\/default\/files\/2024-04\/978-3-031-44080-9.pdf."},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.003_bib0105","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0000000000002209","article-title":"Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders","volume":"33","author":"Kwon","year":"2019","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.003_bib0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/cid\/ciy010","article-title":"Epidemiology and outcomes of hematopoietic stem cell transplantation in human immunodeficiency virus-positive patients from 1998\u00a0to 2012: a nationwide analysis","volume":"67","author":"Mehta","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.bulcan.2026.03.003_bib0115","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bbmt.2009.03.023","article-title":"Allogeneic hematopoietic cell transplantation in human immunodeficiency virus\u00a0\u2013\u00a0positive patients with hematologic disorders: a report from the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Gupta","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.003_bib0120","doi-asserted-by":"crossref","first-page":"e652","DOI":"10.1016\/S2352-3018(20)30117-X","article-title":"Hematopoietic cell transplantation in HIV patients","volume":"7","author":"Ambinder","year":"2020","journal-title":"Lancet HIV"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.003_bib0125","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1016\/S2352-3018(20)30073-4","article-title":"Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study","volume":"7","author":"Durand","year":"2020","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.bulcan.2026.03.003_bib0130","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/14656566.2019.1612364","article-title":"Pharmacotherapeutic management of HIV in transplant patients","volume":"20","author":"Spagnuolo","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.003_bib0135","doi-asserted-by":"crossref","first-page":"e1004406","DOI":"10.1371\/journal.ppat.1004406","article-title":"Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant","volume":"10","author":"Mavigner","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bulcan.2026.03.003_bib0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trim.2017.05.003","article-title":"The recipient CCR5\u00a0variation predicts survival outcomes after bone marrow transplantation","volume":"42","author":"Horio","year":"2017","journal-title":"Transplant Immunol"},{"issue":"5270","key":"10.1016\/j.bulcan.2026.03.003_bib0145","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","article-title":"CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1","volume":"272","author":"Alkhatib","year":"1996","journal-title":"Science"},{"issue":"6594","key":"10.1016\/j.bulcan.2026.03.003_bib0150","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/382829a0","article-title":"The lymphocyte chemoattractant SDF-1\u00a0is a ligand for LESTR\/fusin and blocks HIV-1\u00a0entry","volume":"382","author":"Bleul","year":"1996","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bulcan.2026.03.003_bib0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous defect in HIV-1\u00a0coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1\u00a0infection","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"issue":"7561","key":"10.1016\/j.bulcan.2026.03.003_bib0160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nature.2015.17951","article-title":"French teenager healthy 12\u00a0years after ceasing HIV treatment","volume":"523","author":"Check Hayden","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bulcan.2026.03.003_bib0165","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1016\/S2352-3018(24)00090-0","article-title":"Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study","volume":"11","author":"Salgado","year":"2024","journal-title":"Lancet HIV"},{"issue":"21","key":"10.1016\/j.bulcan.2026.03.003_bib0170","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1002\/cncr.32411","article-title":"Successful anti-CD19\u00a0CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma","volume":"125","author":"Abramson","year":"2019","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.003_bib0175","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/hiv.13514","article-title":"T-cell therapies for HIV-positive lymphoma patients\u00a0\u2013\u00a0a call for action","volume":"24","author":"Hattenhauer","year":"2023","journal-title":"HIV Med"},{"issue":"Suppl. 1","key":"10.1016\/j.bulcan.2026.03.003_bib0180","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1182\/blood-2022-165370","article-title":"Observational cohort study of people living with HIV treated with CD19-directed CAR T cell therapy\u00a0\u2013\u00a0interim results of AMC study AMC-113","volume":"140","author":"Barta","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.003_bib0185","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2352-3026(20)30142-3","article-title":"CAR T cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies","volume":"7","author":"Uldrick","year":"2020","journal-title":"Lancet Haematol"},{"issue":"11","key":"10.1016\/j.bulcan.2026.03.003_bib0190","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcyt.2017.05.013","article-title":"CCR5-edited gene therapies for HIV cure: closing the door to viral entry","volume":"19","author":"Haworth","year":"2017","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1016\/j.bulcan.2026.03.003_bib0195","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41577-018-0042-2","article-title":"CAR T cells for infection, autoimmunity and allotransplantation","volume":"18","author":"Maldini","year":"2018","journal-title":"Nat Rev Immunol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:02:22Z","timestamp":1779282142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126001864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0007455126001864"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.03.003","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques chez des personnes vivant avec le VIH (SFGM-TC)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer.","name":"copyright","label":"Copyright"}]}}